What You Should Know:
The future of healthcare depends on access to digital-first solutions rooted in diagnostic insights that support individuals along their health journey. Everly Health, isn’t just enabling a better lab testing experience, they’re enabling a better diagnostic experience through innovative products and clinical services that are insightful and actionable, leading to more comprehensive treatment with speed that offers overall better outcomes.Additionally, Everly Health
Read More
EverlyWell
Connecting the Dots – Building Data Bridges for a Better Healthcare Future
Healthcare data is increasing at an exponential rate. Approximately one-third of the world’s data volume is being generated by the healthcare industry. By 2025, the compound annual growth rate of healthcare data will reach 36% – that’s 6% faster than manufacturing, 10% faster than financial services, and 11% faster than media and entertainment.
In addition to information captured during visits with healthcare professionals, personal health information is being created by an increasingly
Read More
Everlywell Secures $175M to Expand Position in At-Home Testing Market
What You Should Know:
- Everlywell secures $175M in Series D funding to expand
its virtual care offerings, scale its testing and infrastructure, drive
clinical research and disease management through testing, and grow its national
leadership position in the at-home testing market.
- Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health
Read More
Evidation’s Appoints Co-CEO, Greenway’s New President, Other Health IT Appointments
Evidation’s Board of Directors has appointed Christine Lemke as Co-CEO alongside Executive Chair Deborah Kilpatrick.
Greenway Health appoints Pratap Sarker as President to oversee all commercial and customer-focused functions including sales, marketing, and customer success. He will also work closely with Greenway’s clearinghouse, revenue cycle and IT teams to ensure the delivery of quality solutions that are critically needed to support practices’ business continuity, as well as their
Read More
Collective Health Launches COVID-19 Workplace Solution to Facilitate Safer Workforce Reentry
What You Should Know:
- Collective Health launches COVID-19 workplace solution to help businesses reduce risk and facilitate safe work reentry
- As economic pressure continues to force broader re-openings across the U.S., Collective Go includes a testing ecosystem, occupational health protocol, mobile app, and HIPAA compliant platform.
Collective Health,
a San Francisco, CA-based employee healthcare company with an integrated
technology solution, today announced the launch of
Read More
FDA Approves Everlywell’s COVID-19 Test Home Collection Kit Using Nasal Swabs
What You Should Know:
- FDA approves Everlywell’s COVID-19 Test Home Collection Kit under the emergency use authorization (EUA) allows an individual to self-collect a nasal sample at home using Everlywell’s authorized kit.
- The Everlywell home-collection kit is currently the only authorized COVID-19 at-home sample collection kit for use with multiple authorized COVID-19 diagnostic tests.
The U.S. Food and Drug
Administration (FDA) has issued emergency use authorization (EUA) to
Read More
At-Home COVID-19 Test Kits Will Be Available to U.S. Consumers for $139 on March 23rd
What You Should Know:
- Everlywell announces that an at-home collection kit with telehealth diagnosis for COVID-19 will be available to consumers starting Monday, March 23 for $139.
- The initial offering of 30,000 collection kits will significantly impact total coronavirus testing capacity in the United States; free telehealth consults are included for those with positive results.
- By working with multiple labs to scale infrastructure, the company plans to have testing and diagnosis
Read More
EverlyWell Raises $50M to Scale In-Home Digital Lab Testing Platform
EverlyWell, an Austin, TX-based next-generation healthcare testing platform has raised $50 million in funding led by long-time investors Goodwater Capital with Highland Capital Partners joining. Next Coast Ventures, NextGen Venture Partners, SoGal Ventures and others participated. The company will use the funding to expand its digital platform and scale existing partnerships with leading brands like CVS and Humana.Cumbersome Traditional Lab Testing ProcessOver seven billion lab tests are run
Read More
EverlyWell Partners with Helix to Launch New Suite of DNA Tests
EverlyWell, a next-generation health testing platform has launched three new biomarker and genomics products that will expand its established suite of at-home lab testing kits that provide insights about health and wellness. The new tests, which harness DNA to yield personalized information about food sensitivity, metabolism, and breast milk DHA, were developed in collaboration with Helix, a personal genomics company that today launched the first online marketplace for DNA-based products.
Read More
EverlyWell Raises Additional Capital to Expand Convenient At-Home Health Testing
EverlyWell, an Austin, TX-based next-generation healthcare testing platform has completed another round of funding led by NextGen Venture Partners with Jack Novak, SoGal Ventures, Full Tilt Capital, including participation from other investors. The latest round brings the company’s total funding to $5 million since its inception in 2015.EverlyWell offers a suite of regulatory-compliant, physician-reviewed, at-home lab tests, without a lab visit or an in-person doctor referral. The platform
Read More
